NewsUpstreamUK Firm Secures High-THC Growing Licence

UK Firm Secures High-THC Growing Licence


A PROMINENT UK cannabis company has secured a licence to grow cannabis with a THC ratio of more than 0.2% for research purposes.

Somerset-based Sativa Group says the cannabis cultivated at its new facility will be used to support its research efforts with partner institution Kings College London.

The company already has a licence to grow low-THC cannabis which was granted in 2018.

The Somerset Live website reports that Sativa has an established secure, purpose-built growing facility – which has already been approved by the UK Home Office – as part of the application process.  

It reports that the plants will be grown from the EU-approved seeds and could deliver up to four crops a year, with the dried flower going into an on-site extraction process.

Sativa’s work with King’s College London involves research on the impact of cannabinoids on inflammation and respiratory conditions.

The UK Home Office is responsible for licensing cannabis cultivation and granted the licence to Sativa Group subsidiary Sativa Cultivation and Extraction.

A Freedom Of Information Request by BusinessCann to the Home Office show 19 high-THC licences have been granted in the last year.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you